The emerging treatment of this peptide represents a major development in the management of diabetes mellitus type 2. Unlike existing drugs, tirzepatide affects two pathways – glucagon-like peptide-1 (GLP-1) and GIP https://tirzepatide-peptide033974.blogzet.com/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment-57197257